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Sexual transmission is the major cause of the AIDS epidemic. For the development of new antiviral and vaccine strategies,
we therefore need to understand the mechanisms by which lentiviruses cross the mucosal barrier and the subsequent
pathogenic consequences. For this purpose, experimental approaches are greatly facilitated by the development of relevant
animal models. In this study, macaques were inoculated intravenously, intrarectally, or intravaginally with a pathogenic
cell-free isolate of SIVmac251. Patterns of virological and immunological events significantly differed between vaginally
(transient viremia, late seroconversion) and intravenously or intrarectally inoculated monkeys (persistent viremia and early
seroconversion). Two weeks after infection, analysis of the env gene nucleotide sequences of proviruses recovered from
PBMCs demonstrated that most of the differences were observed in the V1 loop. Three viral variants were specifically
associated with vaginal transmission, whereas no such selection was evidenced after intravenous or intrarectal transmis-
sions. These results are in favor of specific mechanisms associated with vaginal transmission, implicating viral envelope
structure. © 1998 Academic Press
INTRODUCTION
The worldwide dramatic epidemic spread of human
immunodeficiency virus (HIV) (Barre´-Sinoussi et al., 1983)
infection, mainly attributed to sexual contacts, urges the
need for designing new therapeutic and vaccine strate-
gies, which depends on a better understanding of the
complex mucosal infection mechanisms.
The investigation of human HIV mucosal transmission
is limited by the poor access to biological samples within
the very early moments of infection and the difficult
identification of the source of transmitted viruses. The
limited available data in humans tend, however, to con-
firm that although several viral variants may be identified
in blood and genital fluids of transmitters, in the recipient
the genotype and phenotype of transmitted viruses are
homogeneous at the moment of seroconversion (Zhang
et al., 1993; Zhu et al., 1993). This observation argues for
a selection of viruses which cross the mucosal barrier
and strongly suggests that specific mechanisms may
account for sexual HIV transmission.
The in vivo approaches of these mechanisms are
greatly facilitated by the development of particularly well-
adapted animal models of human HIV infection; one of
the most relevant is the experimental infection of ma-
caques with pathogenic strains of SIVmac. This nonhu-
man primate lentivirus shares similar genomic organiza-
tion and biological properties with HIV-1 and HIV-2 (Des-
rosiers, 1990). Interestingly, some SIV strains induce in
macaques an immunodeficiency syndrome which strik-
ingly reproduces human AIDS (Daniel et al., 1985).
Using this animal model, we have designed an exper-
iment in order to determine precisely the pathogenesis
and the virological consequences of a possible selective
pressure exerted by the mucosa. Macaques were ex-
posed to the virus by intravenous, intrarectal, or intravag-
inal routes. Clinical, immunological, and virological out-
comes were compared as well as the nucleotide env
sequences of proviruses recovered from peripheral
blood mononuclear cells (PBMCs) soon after inoculation.
RESULTS
Virological and immunological events following
infection by intravenous, rectal, or vaginal routes
We compared the early pathogenic events following
infection of macaques by the different inoculation routes.
The kinetics of virological and immunological parame-
ters subsequent to intravenous inoculation were previ-
ously characterized (Le Grand et al., 1994) and found to
be absolutely comparable to other reported experiments.
The mean time (days postinoculation (pi) 6 SD) of sero-
conversion, appearance of antigenemia, and cell-asso-
ciated viremia of eight cynomolgus macaques inoculated
by the intravenous (iv) route with 4 iv animal infectious
doses at 50% (iv-AID50) were, respectively, 18.87 6 2.47,
11.37 6 2.13, and 9.25 6 2.18.
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In macaques intrarectally inoculated with different vi-
rus stock dilutions, no major differences were observed
when compared to intravenously inoculated animals (Ta-
ble 1): the mean time (days pi 6 SD) of seroconversion,
appearance of antigenemia, and cell-associated virus
load were, respectively, 22 6 14 (n 5 9), 14 6 2.8 (n 5
11), and 16 6 2.5 (n 5 7). However, the in vivo infectious
titer of this virus stock was reduced approximately 200-
fold after ir compared to iv inoculation.
Contrasting what we described for ir or iv inoculated
animals, such a unique and reproducible pattern of in-
fection was not observed in vaginally inoculated ma-
caques. Interestingly, in half of these monkeys, atrau-
matic vaginal exposure to the pathogenic SIVmac251
resulted in a transient viremia accompanied by a weak
and late antibody response (Table 1) (Le Grand et al.,
1995). Whereas persistently viremic macaques serocon-
verted within a delay similar to that observed for iv or ir
infected animals (3 to 6 weeks following inoculation),
transiently viremic macaques 374B and 46720 serocon-
verted at 12 weeks pi. No antigenemia was detected in
these two macaques (Table 1). This particular infection
pattern did not seem to be related to the inoculated dose
or the presence of seminal plasma in the inoculum. By
contrast, in our experiment, using this same virus stock
at even low infectious doses (Le Grand et al., 1994; Le
Grand and Dormont, 1993), no such transient infection
was observed in animals inoculated by the iv or ir route
(Table 1).
Genetic characterization of transmitted viruses
In order to investigate whether the route of infection
resulted in the transmission of specific SIVmac251 vari-
ants, we directly sequenced and compared the env gene,
from variable regions V1 to V5, of proviruses obtained
from PBMCs of 8, 5, and 6 infected animals inoculated by
vaginal, rectal, or intravenous routes, respectively. Two of
the vaginally inoculated monkeys exhibited a transient
viremia (macaques 46720 and 374B). To avoid genetic
variation under host immune pressure, day 14 postexpo-
sure samples were analyzed, except for a transiently
viremic, vaginally inoculated monkey (46720) whose first
detection of SIV provirus in PBMCs was obtained at 12
weeks pi. For all animals, later time point env sequences
were also analyzed to confirm the predominance of the
env sequences described below.
Among the proviruses identified at day 14 pi, we ob-
served, accordingly with other reports (Almond et al.,
1992; Overbaugh et al., 1991), that most of the envelope
genotype diversity resided in the first (V1) and fourth (V4)
variable regions (data not shown). However, in our study,
whereas V1 nucleotide sequences displayed a mean of
only 41% similarity with the consensus sequence of SIV-
mac251, substantially more sequence homology (93%)
was found in V4. Therefore, we focused our work on the
V1 loop, using a direct solid-phase sequencing method.
This technique was previously shown to give results
comparable to sequencing of multiple clones in deter-
TABLE 1
PCR Detection of SIV in PBMC and ELISA Detection of SIV-Specific IgG in Plasma from Macaques Inoculated
by Vaginal (ivAG), Rectal (ir), and Intravenous (iv) Routes
Animals Inoculation route
Results at pi week: SIV detection in PBMC/presence of SIV-specific antibodies in plasma
1 2 3 4 6 12 20 30 50 65 90
46683 ivAG 2/2 1/2 1/1 1/1 1/1 1/1 1/1 1/1
46691 ivAG 1/2 1/2 1/1 1/1 1/1 1/1 1/1 1/1 2/1 1/1 1/1
46720 ivAG 2/2 2/2 2/2 2/2 2/2 1/1 2/1 1/1 2/1 2/1 2/1
J143 ivAG 2/2 1/2 1/1 1/1 1/1 1/1 1/1
J482 ivAG 2/2 1/2 1/2 1/1 1/1 2/1 1/1
374B ivAG 2/2 1/2 2/2 2/2 1/2 2/1
I872A ivAG 1/2 1/2 1/2 1/2 1/1 2/2 2/2 1/1
46681 ivAG 1/2 1/2 1/2 1/2 1/1 1/2 2/2 1/1 1/2 1/2 1/1
49098 ir NT/2 1/2 1/NT 1/1 NT/1 1/1
49105 ir NT/2 1/2 1/NT 1/1 NT/1 1/1 NT/1 NT/1 NT/1 1/1 1/1
49100 ir NT/2 1/2 1/NT 1/1 NT/1 1/1 NT/1 NT/1 NT/1 1/1 1/1
49091 ir NT/2 1/2 1/NT 1/1 NT/1 1/1 NT/1 NT/1 NT/1 1/1 1/1
49088 ir NT/2 1/2 1/NT 1/1 NT/1 2/1 NT/1 NT/1 NT/1 1/1 1/1
J849 iv 2/2 1/1 1/1 1/1 1/1 1/1
J882 iv 2/2 1/1 1/1 1/1 1/1 1/1
J644 iv 2/2 1/2 1/1 1/1 1/1 1/1
I823A iv 2/2 1/2 1/1 1/1 1/1 1/1
46713 iv 1/2 1/1 1/1 1/1 1/1 1/1
46880 iv 2/2 1/2 1/2 1/1 1/1 1/1
Note. 1, positive detection; 2, negative detection; and NT, available sample not tested.
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mining the predominant nucleotide viral sequence in
PBMCs isolated from infected patients (Leitner et al.,
1993; Scarlatti et al., 1993). From our analysis, we de-
duced a phylogenetic tree showing that the sequences
in V1 may be distributed among five major groups (Fig.
1). Interestingly, this analysis revealed a nonrandom dis-
tribution of the routes of infection among these five
clusters; the deduced peptide sequences are presented
in Fig. 2.
Group 1 contains the predominant V1 genotypes of
four of the eight animals infected by the vaginal route
and the sequence of only one of the six iv infected
macaques. V1 peptide sequences from group 1 are char-
acterized by the presence of a potential N-glycosylation
site (N-X-T motif) which is not encountered in the con-
sensus sequence of SIVmac251 and in the other sub-
types presented here.
V1 sequences of the other vaginally infected ma-
caques, including those which exhibited a transient vire-
mia (46720 and 374B), were equally distributed among
groups 4 and 5. The former includes also the sequence
of the major V1 variant of monkey 46683 at 3 weeks pi,
although its major genotype identified at day 14 pi was
classified in group 2 as described below. Finally, the
sequences of one ir (49088) and one iv inoculated mon-
key (I823A) were also found to be homologous to the
group 5 consensus sequence. Although the major viral
variant recovered from our virus stock displayed a V1 the
FIG. 1. Phylogenetic dendogram of the V1 (nucleotid 6948 to 7020) env DNA sequences recovered at day 14 pi (day 87 pi for macaque 46720) from
PBMCs of macaques inoculated by intravenous (IV), intrarectal (IR), or intravaginal (IVAG) routes. Multiple DNA sequence alignments generated with
CLUSTALW were resampled (bootstrap, 100 data sets) using SEQBOOT (PHYLIP). The consensus neighbor-joining dendogram (DNADIST; NEIGH-
BOR; CONSENSE, PHYLIP) is based on distances calculated by the two-parameter model of Kimura. The numbers at the forks indicate the number
of times the group consisting of the species to the right of that fork occurred among the 100 trees. The numbers included at the right refer to the
numeral of the group in which the macaque V1 peptide sequences are classified (see Fig. 2). SIV stock refers to the major nucleotide V1 sequence
recovered from the inoculated virus stock. SIVmac251 refers to the consensus sequence of the SIVmac251. 46683 (2) refers to the V1 sequence
recovered from macaque 46683 at 21 days pi.
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peptide sequence similar to the group 5 consensus se-
quence (Fig. 2), it was not the predominant genotype
recovered from animals infected by the iv or ir routes.
Three of the six animals infected by the iv route, and
two of the five macaques infected by the ir route, as well
as only one vaginally inoculated monkey (46683), exhib-
ited V1 sequences of genotype 2. It must be noted that,
in this group, as observed in cluster 1, two series of
sequences with different lengths were identified. One
was characterized by the insertion of 3 bp encoding for
an alanine at position 19 of the V1 loop and seemed to be
associated only with iv transmission.
The third group of V1 genotypes is composed of three
identical sequences from one intravenously and two in-
trarectally infected animals.
Distribution of viral variants in different tissues
In summary, we demonstrated that the virus variants
identified early after infection from seven of the eight
intravaginally infected macaques are grouped in three of
the five distinct patterns of V1 genotypes. To verify that
variants clustering with groups 2 and 3, which are not
present in blood of the macaques infected by vaginal
route, are sequestered in neither mucosal or lymphoid
tissues, we analyzed and compared the number and
sequence of viral variants detected in PBMCs, cervico-
vaginal secretions (CVS), or peripheral lymph node
mononuclear cells (LNMCs) of three vaginally infected
macaques displaying V1 sequences clustering in group
1 in blood at day 14 pi. For this purpose we performed a
single-strand conformation polymorphism analysis of
polymerase chain reaction products (PCR-SSCP). This
method enables the separation of different single-
stranded DNA on the basis of the composition of their
nucleotide sequence by migration in a nondenaturing
polyacrylamide gel (Hayashi, 1991; Hynes et al., 1993). In
all samples from macaques J143 and 46681, only one
band, corresponding to the patterns of migration of se-
quences analogous to the group 1 consensus, was evi-
denced (Fig. 3). In samples from macaque J482, two
bands, corresponding to two distinct viral variants, were
identified. Those representing the group 1 sequence are
located in the upper third of Fig. 3. This V1 variant,
according with direct sequence data, seems to represent
the major variant recovered from PBMCs and LNMCs
from macaque J482. Conversely, in this same animal,
PCR-SSCP analysis and sequence determination re-
vealed that one other variant was predominant in CVS at
day 14 pi. This V1 peptide sequence did not cluster in
one of the five genotypes described above (Fig. 2).
Figure 4 shows the characteristic PCR-SSCP patterns
of migration of the different V1 SIV variants recovered
from monkeys included in this study. All identical DNA V1
sequences migrated to the same locus. To conclude, we
never identified variants clustering in groups 2 or 3 in
PBMCs of all vaginally infected animals except monkey
46683, in which at least two viral species, analogous to
the group 2 and 5 sequences, were recovered (Fig. 4).
Finally, using PCR-SSCP, we evidenced the presence of
more than one viral variant in only two of the eight
vaginally infected animals compared to four of the six iv
infected animals and three of the five ir inoculated ma-
caques (Fig. 4).
DISCUSSION
In this study, macaques were infected with the same
cell-free pathogenic SIVmac251 stock by iv, ir, or vaginal
atraumatic single inoculation. The parameters of infec-
tion we observed were almost similar in iv and ir infected
animals, whereas an atypical pattern of infection was
evidenced in some macaques inoculated by the vaginal
FIG. 2. Deduced amino acid sequence alignments of the V1 region of
SIV gp120 from PBMCs of intravaginally (IVAG), intrarectally (IR), or
intravenously (IV) infected macaques at day 14 pi (day 87 pi for ma-
caque 46720). Peptide sequences were clustered into five groups on
the basis of the phylogenetic dendogram derived repartition (Fig. 1).
Predominant viral variant recovered from the virus inoculum is indi-
cated as SIV stock; 46683 (2) refers to the V1 sequence recovered from
PBMCs of animal 46683 at day 21 pi; J482 (CVS) refers to predominant
V1 sequence recovered from cervicovaginal secretions of macaque
J482 at day 14 pi. Dots indicate sequence identity and dashes indicate
deletions.
15SELECTIVE MUCOSAL EXPERIMENTAL TRANSMISSION OF SIV
route, characterized by transient detection of proviral
DNA and a weak and delayed antibody response. Such
an infection pattern was previously reported by others
after vaginal inoculation of macaques with SIV (Miller et
al., 1994). However, although transient viremia were ob-
served also after ir inoculation of SIV (Pauza et al., 1994),
in our experiment, all the ir exposed monkeys exhibited
a persistent viremia and an early and strong anti-viral
immune response, even when low doses of virus were
inoculated (Le Grand and Dormont, 1993). Nevertheless,
this apparent discrepancy may be attributed to the origin
of the viral stocks used. Indeed, the SIV prepared by
Pauza et al. (1994) was grown on human cells which may
have selected viral variants with different biological prop-
erties than primary isolates grown on monkey cells
(Hirsch et al., 1989). Our virus stock was obtained from a
cell-free supernatant of SIVmac251-infected rhesus PB-
MCs and was never passaged on human PBMCs or cell
lines. In vitro, this virus replicates on human T cell lines,
simian and human PBMCs, as well as simian primary
astrocytes and monocyte/macrophages (Guillemin et al.,
1996). Therefore, this SIVmac251 strain shares common
properties with HIV primary isolates.
Several virological and/or host factors may account for
the different infection profiles we observed between
routes of experimental inoculation of SIV. One of the
possible explanations is that specific SIV variants may
be selected by the exposed mucosa. We therefore ana-
lyzed the env gene of transmitted viruses by a direct
sequencing method. As previously reported (Leitner et
FIG. 3. PCR-SSCP analysis of DNA from cervicovaginal secretions (CVS), lymph node mononuclear cells (LNMCs), and PBMCs of intravaginally
inoculated macaques J482, J143, and 46681. The V1 and flanking regions (nucleotides 6847 to 7133) of the SIV envelope from the indicated tissues
of the three infected macaques were analyzed. The bands in the upper half of each V1 autoradiogram have been sequenced and correspond to the
single-stranded conformation of the group 1 V1 sequences.
FIG. 4. PCR-SSCP analysis of V1 env DNA sequences obtained from
PBMCs of (A) intravaginally (IVAG), (B) intrarectally (IR), or (C) intrave-
nously (IV) inoculated macaques. The V1 and flanking regions (nucle-
otides 6847 to 7133) of the SIV envelope were analyzed. Respective
locations of sequences analogous to the group 1 to 5 genotypes were
confirmed by sequence analysis of the bands and are indicated by
arrows.
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al., 1993; Scarlatti et al., 1993), this technique allows the
determination of the predominant nucleotide viral se-
quence in virus-infected cells. Furthermore, in our exper-
iment, sequence analysis of the major bands obtained
from PCR-SSCP analysis revealed that these bands al-
ways corresponded to the major nucleotide sequence
obtained from direct sequencing of animal samples.
We confirmed, as reported by others (Almond et al.,
1992, Overbaugh et al., 1991), that variability in the enve-
lope of SIVmac251 is mainly located in the first variable
loop. In our animals, we identified five major transmitted
genotypes with respect to their V1 nucleotide se-
quences. V1 sequences recovered from the majority of
vaginally infected macaques were distinct from those
recovered from the majority of the intravenously or in-
trarectally infected animals. SIV variants identified early
after infection from seven of the eight vaginally infected
macaques were grouped in three of the five distinct
patterns of V1 genotypes, namely groups 1, 4, and 5.
Based on PCR-SSCP analysis of LNMCs and CVS ob-
tained from vaginally infected animals (Fig. 3), we may
assume that the absence of sequences analogous to the
variants clustering in groups 2 and 3 in PBMCs from
vaginally infected animals (at the exception of macaque
46683) was not due to a restricted replication of these
variants in the peripheral lymph nodes or mucosal tis-
sues we tested. Therefore, this viral selection was likely
to take place at the first entry step, the vaginal mucosa.
However, we cannot exclude from our experiment that
the absence of vaginal transmission of genotypes 2 and
3 in seven of the eight vaginally infected animals may
reflect a limited viral replication of these variants in a
tissular compartment that was not assessed.
In this experiment, we cannot distinguish between the
proviruses obtained from transiently or persistently in-
fected monkeys. Nevertheless, among vaginally infected
animals, four of the six persistently viremic macaques
exhibited a V1 sequence analogous to the group 1 ge-
notypes. Interestingly, these variants are characterized
by the presence of an additional potential N-glycosyla-
tion site. Overbaugh et al. (1992) already reported that
during evolution of chronic SIV infection in macaques,
new sites for N-linked glycosylation can appear in the V1
region, which may confer to these variants a selective
advantage. We may therefore hypothesize that viruses
displaying the group 1 V1 loop are favored, by virtue of
their phenotype, in the efficient crossing of the vaginal
mucosa compared with the other variants described
here.
Finally, in this experiment, we cannot conclude, as
previously suggested (Trivedi et al., 1994), that there is a
selection of particular viral genotypes after ir inoculation
compared with the sequences obtained from iv-infected
macaques. These results are concordant with the viro-
logical data we observed.
This study emphasizes the specific selective pressure
exerted by the vaginal mucosa compared to the rectal
mucosa and points out the fact that different transmis-
sion mechanisms may be involved for crossing through
these two structurally distinguishable epithelium barriers
(Fawcett, 1994).
Indeed, the vagina and exocervix exhibit a stratified
epithelial cell layer and a submucosa which include
different cell types that may be infected by HIV as Lang-
erhans dendritic cells (LDC), macrophages, and CD41 T
lymphocytes. Recent studies suggest that LDC may be
actively implicated in experimental vaginal SIV transmis-
sion in macaques (Spira et al., 1996) as well as sexual
HIV transmission in humans (Soto-Ramirez et al., 1996).
The rectum is covered by a simple epithelial mono-
layer (Fawcett, 1994); this cell composition does not
include Langerhans cells (Lehner et al., 1991). However,
this mucosa is composed of several cell types which
may be susceptible to HIV infection, including epithelial
cells, through the galactosyl-ceramide receptor (Fantini
et al., 1993), and intraepithelial T lymphocytes, although
no in vivo evidence of their infection has been described
to date. Epithelial cells or the antigen-carrier M cells
(Amerongen et al., 1991; Bomsel, 1997) may also un-
selectively facilitate the transmission of viruses by trans-
cytosis from the lumen to the lamina propria, where HIV
may infect the resident macrophages and CD41 T cells
before its release in lymphatic organs or bloodstream.
Our study provides, in a relevant animal model, clear
evidence that different lentivirus genotypes may be dis-
tinguished by the route of transmission. These results
emphasize also that the first variable loop of the enve-
lope glycoprotein of SIVmac251 may be implicated in the
interactions with the target cells the virus may encounter
in vivo during sexual transmission. These cells, which
therefore probably play a key role in the selection of
infecting viral variants, may not be identical in the vaginal
and in the rectal mucosa. As the transmitted viruses
should be the target of vaccine strategies, further studies
on their biological and antigenic properties could be of
interest for the development of new vaccine approaches.
MATERIALS AND METHODS
Animals
Cynomolgus (Macaca fascicularis) or rhesus ma-
caques (Macaca mulata) were imported from Mauritius
island and were housed in single cages within level 3
biosafety facilities. All macaques were negative for SIV,
STLV (simian T lymphotropic virus), Herpes-B, Filovirus,
SRV-1, SRV-2, measles, hepatitis B-HB sAg, and hepatitis
B-HB CAb before SIV inoculation. Animals were clinically
examined periodically under ketamine chlorhydrate an-
esthesia (Rhone-Me´rieux, Lyon, France). All experimen-
tal procedures were conducted according to institutional
guidelines for animal care (‘‘Journal Officiel des Commu-
naute´s Europe´ennes,’’ L358, 18 December 1986).
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Virus
The pathogenic SIVmac251 cell-free virus stock was
kindly provided by Dr. A. M. Aubertin (Universite´ Louis
Pasteur, Strasbourg, France). This virus was grown on
rhesus peripheral blood mononuclear cells (rhPBMCs)
infected in vitro with a culture supernatant obtained from
a coculture of rhPBMCs and spleen lymphocytes from a
rhesus macaque infected with SIVmac251 (provided by
Dr. R. C. Desrosiers, New England Regional Primate
Research Center, MA). Using the method proposed by
Spouge (1992), the in vivo titer of this stock was esti-
mated to be 4 3 104 animal infectious doses at 50% per
ml after iv inoculation of macaques (iv-AID50), 2 3 10
2 per
ml after atraumatic intrarectal exposure (ir-AID50) (Le
Grand and Dormont, 1993), and 67 per ml after atrau-
matic vaginal exposure (ivAG-AID50).
Intravenous inoculation of macaques
Macaques were inoculated into the saphenous vein
with 1 ml of a 1024 dilution of the virus stock diluted in
PBS, corresponding to 4 iv-AID50.
Intravaginal inoculation of macaques
Four weeks before SIV inoculation, animals were
treated with three intramuscular injections of 50 mg of
estradiol benzoate (Laboratoires Roussel, Paris, France)
at 48-h intervals. One milliliter of 10-fold dilutions of the
virus stock was prepared in PBS. Before inoculation, final
dilution was completed to 2 ml with PBS alone or undi-
luted human seminal plasma. The inoculation procedure
involved deposition of either 2 ml of cell-free SIV diluted
in PBS or 2 ml of cell-free SIV diluted in PBS containing
50% of human seminal plasma (hu-SP) into the vaginal
vault using a soft-plastic tube originally intended for
artificial insemination of dogs (Centravet, Lyon, France).
Animals remained immobile for at least 15 min after
inoculation. The dilutions of virus used were 5 3 1022
corresponding to 3.3 ivAG-AID50 (macaques 46691,
46720, J143, J482, and 46683) and 5 3 1023 correspond-
ing to 0.33 ivAG-AID50 (macaques 46681, 374B, and
I872A).
Intrarectal inoculation of macaques
Macaques were submitted to 48 h of hydric diet. One
milliliter of 10-fold dilutions of the virus stock was pre-
pared in PBS. Before inoculation, final dilution was com-
pleted to 3 ml with PBS. The inoculation procedure in-
volved deposition of 3 ml of cell-free SIV diluted in PBS
into the rectal vault using a smooth pediatric nasophar-
yngial tube. The virus dilutions used were 100 corre-
sponding to 2 3 102 ir-AID50 (macaques 49098, 49105),
1021 corresponding to 2 3 101 ir-AID50 (macaque 49100),
and 1022 corresponding to 2 ir-AID50 (macaques 49091,
49088). Macaques remained immobile for at least 15 min
after inoculation.
Sample collection and PCR amplification
Blood samples were collected weekly for hemato-
logical, virological, and immunological analyses dur-
ing 4 weeks after inoculation and monthly thereafter.
Washes of the vaginal canal with 2 ml of sterile PBS
were performed. Vaginal cells were separated from
supernatant by 500g centrifugation and washed four
times with PBS before being prepared for PCR assays.
Fresh macaque PBMCs and LNMCs were isolated by
Ficoll gradient separation (Eurobio, Les Ulis, France).
DNA was extracted from PBMCs, LNMCs, and cells
from vaginal washes (Le Grand et al., 1994). For de-
tection of SIVmac251 provirus, DNA was amplified
using nested sets of primers specific for env and gag
SIVmac251 genes (provided by the European Vaccine
Against AIDS program, National Institute for Biological
Standards and Control, Potters Bar, United Kingdom).




CCTCACAAGAGCGTGAGCTCAAG. The gag outer and
inner primer pairs were 1386-N-GAAACTATGCCAAAAA-
CAAGT, 2129-C-TAATCTAGCCTTCTGTCCTGG; and 1731-
N-CCGTCAGGATCAGATATTGCAGGAACAACT, 2129-C-
TAATCTAGCCTTCTGTCCTGG. A nested set of primers
specific for pol was used to confirm the results obtained
with the env and gag primers. The pol outer and inner




For sequence analysis, the env gene of SIVmac251
was amplified from 1 mg of the total genomic DNA, a
previously described classical reaction mixture (Le
Grand et al., 1994), and an outer pair of primers:
6597-N-TCAGCTGCTTATCGCCATCGCCATCTTGC, 8208-C-
AGAACCTGCCGTTGCGAAAACC; 35 main cycles were
run (94°C for 45 s, 55°C for 2 min, and 72°C for 1 min).
Two microliters of the first amplification mixture was
used as template in a second round of amplification
using the inner primer pairs spanning the region from
V1 to V3: 6847-N-GTATGGCAACTCTTTGAGACCTCAATA,
7778-C-TCTCCTTCTGCAATTTGTCCACAT; and V3 to V5:
7410-N-TGGCTTTAATGGAACTAGAGCA, 8208-C-AGAAC-
CTGCCGTTGCGAAAACC.
Detection of anti-SIV IgG in plasma by ELISA
Anti-SIV antibodies were detected in plasma as previ-
ously described (Le Grand et al., 1994) using an HIV-2
detection assay (ELAVIA II kit; Sanofi Diagnostis Pasteur,
Marnes-la-Coquette, France). As second antibody, the
anti-human IgG provided by the manufacturer was re-
placed by peroxidase-labeled goat anti-monkey IgG (Or-
ganon, Teknika, the Netherlands).
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Sequence analysis, alignments, and phylogenetic tree
determination
A direct solid-phase sequence analysis was per-
formed using the ABI PRISM Dye Terminator kit (Perkin–
Elmer, CA) and the inner set of primers described above
according to the manufacturer’s procedures. Sequences
were analyzed using the Sequence Navigator software
(Applied Biosystems, CA); multiple alignments and phy-
logenetic tree were determined with CLUSTALW (Thomp-
son et al., 1994) and PHYLIP (Felsenstein, 1993) software.
Sequence analysis of the viral stock
Viral RNA was obtained from 1 ml of the viral stock by
ultracentrifugation (100,000g for 5 min) and lysis with
RNAble (Eurobio, Les Ulis, France). Extraction of RNA
and reverse transcription were performed according to
previously published protocols (Che´ret et al., 1996).
Briefly, total RNA was subjected to first-strand cDNA
synthesis for 1 h at 42°C in a mixture containing 0.25 M
Tris–HCl, 0.375 M KCl, 15 mM MgCl2, 30 U recombinant
RNase inhibitor (Clontech, Palo Alto, CA), 30 mM each
dNTP, 0.3 mg oligo(dT) (Sigma), and 150 U Moloney
murine leukemia virus reverse transcriptase (Gibco BRL,
Grand Island, NY). After completion of first-strand syn-
thesis, 10 ml of the reaction mixture was used for PCR
with the env primers and sequenced as described
above.
Single-strand conformation polymorphism analysis of
PCR products (PCR-SSCP)
Products from the first-round PCR amplification mix-
ture were used as template in a second round using the
inner primer pair 6847-N and 7778-C spanning the region
from V1 to V3 (25 pmol each), [a-33P]dATP (18.5 MBq)
(Amersham, USA), dNTP (10 mM each), Taq polymerase
buffer, and 0.5 units of Taq polymerase (Appligen, Illkirch,
France). To obtain a limited size of the DNA (286 bp) for
a better migration, the products of the PCR were di-
gested with 5 units of restriction enzyme RsaI (16 h,
37°C), cleaving the env gene at positions 7133 and 7149.
Samples were diluted 1:1 in stop solution (U.S. Biochemi-
cals), denatured, and loaded into a nondenaturing poly-
acrylamide gel (Long-Ranger 6% (US Biochemicals),
glycerol 5%) for migration during 6 h at 30 W and room
temperature. The gel was dried and autoradiographied.
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